This inventor holds 1 USPTO granted patent. Top assignee: 4Sc Ag. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Andreas Wuzík: Innovator in Heterocyclic NF-κB Inhibitors
Introduction
Andreas Wuzík is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit NF-κB, a key player in various inflammatory and autoimmune diseases.
Latest Patents
Wuzík holds a patent for "Heterocyclic NF-κB inhibitors." This invention relates to compounds of the general formula (I) and their salts and physiologically functional derivatives. The patent outlines various configurations for the compounds, including different substituents that can be attached to the core structure, which enhances their therapeutic potential.
Career Highlights
Andreas Wuzík is currently employed at 4SC AG, a company focused on developing innovative therapies for cancer and autoimmune diseases. His work at 4SC AG has positioned him as a key figure in the research and development of novel pharmaceutical solutions.
Collaborations
Wuzík collaborates with esteemed colleagues such as Johann Leban and Harald Schmitt. Their combined expertise contributes to the advancement of research in the pharmaceutical sector.
Conclusion
Andreas Wuzík's contributions to the field of NF-κB inhibitors exemplify the impact of innovative research in medicine. His work continues to pave the way for new therapeutic options in treating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile